inait announces collaboration with Microsoft to deploy novel AI based on digital brains across industries

AI with digital brains: inait & Microsoft collaborate to deploy unique neuroscience-inspired technology across industries, with an initial focus on finance and robotics applications.

2025-03-18

(Press-News.org) Zürich/Lausanne, Switzerland – 18 March 2025 – inait today announced a collaboration with Microsoft to accelerate the development and commercialization of inait’s innovative AI technology, using its unique digital brain AI platform. The collaboration will focus on joint product development, go-to-market strategies, and co-selling initiatives, initially targeting the finance and robotics sectors.

inait's AI technology, born from decades of neuroscience research offers a paradigm shift in artificial intelligence. Its “brain programming language” and ability to learn from experience and understand cause and effect delivers cognitive abilities for real-world interactions towards adaptive general intelligence, overcoming the limitations of current AI systems.

“This collaboration with Microsoft marks a pivotal moment for inait,” said Henry Markram, Founder and Chairman of inait. “After two decades of R&D we now have digital brain replicas and the know-how to teach them to perform AI. Microsoft’s global ecosystem is ideal to globally scale our disruptive digital brain-based AI.”

“Together with Microsoft, we aim to deploy our existing AI solutions and co-develop transformative industry solutions going forward,” stated Richard Frey, CEO of inait.

“inait is pioneering a new AI paradigm—moving beyond traditional data-based models to digital brains capable of true cognition. Their AI models mirror biological intelligence in a highly efficient manner, becoming a leading contender in the new reasoning-driven AI era.” said Adir Ron, EMEA Cloud & AI Director for Startups and Digital Natives Microsoft.

“We believe that inait’s approach to AI has the potential to bring significant value to the industry,” said Catrin Hinkel, CEO Microsoft Switzerland. “Their neuroscience-inspired technology is truly innovative, and we are pleased to collaborate with them to bring these advancements to market, starting with the fintech and robotics sectors where we see opportunities for immediate transformation.”

The collaboration will use the Microsoft Azure cloud platform and its global reach to accelerate the deployment of inait’s AI solutions. In the financial sector, the collaboration will focus on delivering advanced trading algorithms, risk management tools, and personalized financial advice. In robotics, the focus will be on developing more intelligent and adaptable robots for industrial manufacturing capable of performing in complex and dynamic environments.

About inait

inait (www.inait.ai) is a Swiss-based AI innovator developing the next generation of artificial intelligence based on digital brain technology. Founded by neuroscientist Henry Markram and with the Open Brain Institute (www.openbraininstitute.org) as its strategic partner for access to digital brains, inait is pioneering a paradigm shift in AI, delivering adaptive generalizable intelligence for applications across industries.

Press Contact: Richard Frey (CEO), press@inait.ai

END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

The Open Brain Institute announces the dawn of a new frontier in neuroscience

2025-03-18

LAUSANNE, March 18, 2025 – The Open Brain Institute (OBI) launches today as a groundbreaking non-profit organization, transforming neuroscience from the physical to the virtual world. Building on the pioneering achievements of the EPFL’s Blue Brain Project, OBI opens the era of simulation neuroscience—empowering researchers to build and simulate digital brains with unprecedented detail, scale, and speed. AI has been given access to the software recipe to build digital brains, providing natural language support to researchers to explore, build and ...

Helicobacter pylori treatment practices in the Asia-Pacific region

2025-03-18

Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high in the Asia-Pacific region. Approximately 90% of cases are linked to H. pylori bacterial infections, but preemptive eradication can reduce the incidence of gastric cancer by 30-40%. However, the increase in antimicrobial drug-resistant bacteria used in eradication therapy is a major issue. In addition, while secondary prevention through endoscopic examinations is also important for the early detection of gastric cancer, it is not clear to what extent Asia-Pacific practitioners recognize its importance. An international ...

Nearly one in ten unsure if they have Long Covid

2025-03-18

UNDER EMBARGO UNTIL 00:01 AM UK TIME ON TUESDAY 18 MARCH 2025 Almost one in ten people (9.1%) in England think they could have Long Covid but aren’t sure, according to a new analysis of NHS England survey data by the University of Southampton. Researchers also found that 4.8% of people reported having Long Covid, with higher rates among people living in deprived areas, people with particular ethnic backgrounds, parents or carers, and those with another long-term condition. The findings are published today [18 March] ...

Scientists unlock new dimension in light manipulation, ushering a new era in photonic technology

2025-03-18

Researchers at Heriot-Watt University have made a ground-breaking discovery paving the way for a transformative era in photonic technology. For decades, scientists have theorised the possibility of manipulating the optical properties of light by adding a new dimension—time. This once-elusive concept has now become a reality thanks to nanophotonics experts from the School of Engineering and Physical Sciences in Edinburgh, Scotland. The team’s breakthrough emerged from experiments with nanomaterials known as transparent conducting oxides (TCOs) - a special ...

Current antivirals likely less effective against severe infection caused by bird flu virus in cows’ milk

2025-03-17

(MEMPHIS, Tenn. – March 17, 2025) As the H5N1 avian influenza outbreak continues, scientists are working to better understand the virus’s threat to human health. The virus has been found in dairy cows’ milk and has infected farm workers, prompting scientists at St. Jude Children’s Research Hospital to study potential treatments. Results showed that in a preclinical model, two FDA–approved flu antivirals generally did not successfully treat severe H5N1 infections. Additionally, the researchers found that the route of infection, whether through ...

Lassa fever vaccine enters phase 1 clinical trial

2025-03-17

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the Center of Vaccine Development and Global Health, UMB. Currently, there are no approved vaccines against the Lassa virus. The clinical study is a dose-ranging study that will assess the safety and immunogenicity of the candidate vaccine for both the rabies virus and LASV. The experimental vaccine is based on an attenuated and killed rabies virus vaccine similar to current rabies vaccines and has an additional ...

Institute for Healthcare Improvement Honors Hebrew SeniorLife’s Orchard Cove and NewBridge on the Charles

2025-03-17

Outpatient primary care clinics at Hebrew SeniorLife’s Orchard Cove and NewBridge on the Charles communities have been recognized by the Institute for Healthcare Improvement (IHI) as Age-Friendly Health Systems — Committed to Care Excellence. “I want to express my gratitude to the team at Hebrew SeniorLife for your dedication to age-friendly care,” said Leslie Pelton, MPA, Vice President, Institute for Healthcare Improvement (IHI). “Age-Friendly Health Systems and IHI celebrate your recognition as an Age-Friendly ...

Dialing in the temperature needed for precise nuclear timekeeping

2025-03-17

For decades, atomic clocks have been the pinnacle of precision timekeeping, enabling GPS navigation, cutting-edge physics research, and tests of fundamental theories. But researchers at JILA, led by JILA and NIST Fellow and University of Colorado Boulder physics professor Jun Ye, in collaboration with the Technical University of Vienna, are pushing beyond atomic transitions to something potentially even more stable: a nuclear clock. This clock could revolutionize timekeeping by using a uniquely low-energy transition within the nucleus of a thorium-229 atom. This transition is less sensitive to environmental disturbances than modern atomic clocks and has been proposed for tests of fundamental ...

Fewer than half of Medicaid managed care plans provide all FDA-approved medications for alcohol use disorder

2025-03-17

FOR IMMEDIATE RELEASE Monday, March 17, 2025 Contact: Jillian McKoy, jpmckoy@bu.edu Michael Saunders, msaunder@bu.edu ## As health complications and deaths from alcohol use disorder (AUD) increase in the United States, it is critical that people who could benefit from medications have access to the drugs that the US Food and Drug Administration has approved to treat AUD. Yet, for individuals who have alcohol use disorder and are covered by Medicaid, accessing these medications is difficult; past research indicates that only about 1 in 20 Medicaid enrollees with alcohol use disorder receive these ...

Mount Sinai researchers specific therapy that teaches patients to tolerate stomach and body discomfort improved functional brain deficits linked to visceral disgust that can cause of food avoidance in

2025-03-17

Mount Sinai Researchers Find Specific Therapy That Teaches Patients to Tolerate Stomach and Body Discomfort Improved Functional Brain Deficits Linked to Visceral Disgust That Can Cause Food Avoidance in Adolescent Females with Anorexia Nervosa and other Low-Weight Eating Disorders Corresponding Author: Kurt P. Schulz, PhD, Associate Professor, Center of Excellence in Eating and Weight Disorders, Icahn School of Medicine at Mount Sinai, New York, and other co-authors Bottom Line: A trial of interoceptive exposure - a therapy that teaches patients how to tolerate stomach and body discomfort in order to reduce restrictive eating - improved functional deficits in a brain region ...

LAST 30 PRESS RELEASES:

New ‘shy’ fungus found in old-growth forest

Some nicotine pouch flavors much more addictive than others

Low doses of antibiotic work just as well as higher ones to treat rare type of chronic hair loss

Social media pressures could make friendship a full-time job

CD2AP and Alzheimer’s disease: A key regulator of neurodegeneration and potential therapeutic target

Maternal infection disrupts newborn brain development: A link to neurodevelopmental disorders